rdf:type |
|
lifeskim:mentions |
umls-concept:C0006142,
umls-concept:C0016360,
umls-concept:C0079419,
umls-concept:C0205179,
umls-concept:C0205313,
umls-concept:C0444889,
umls-concept:C0449438,
umls-concept:C0681842,
umls-concept:C0871261,
umls-concept:C1516213,
umls-concept:C1517927,
umls-concept:C1521733,
umls-concept:C1522326,
umls-concept:C1522449,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C2911692
|
pubmed:issue |
5
|
pubmed:dateCreated |
1997-12-11
|
pubmed:abstractText |
1) To test feasibility of preoperative continuous infusion (c.i.) 5-Fluorouracil (5-FU) and radiation (RT) in locally advanced breast cancer. 2) To study clinical and pathological response rates of 5-FU and radiation. 3) To attempt preliminary correlations between biological probes and pathological response.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0360-3016
|
pubmed:author |
pubmed-author:DanenbergKK,
pubmed-author:DanenbergPP,
pubmed-author:DunningtonGG,
pubmed-author:FlorentineBB,
pubmed-author:FormentiS CSC,
pubmed-author:GOODF HFH,
pubmed-author:GroshenSS,
pubmed-author:Keren-RosenbergSS,
pubmed-author:LeichmanGG,
pubmed-author:LenzHH,
pubmed-author:MuggiaFF,
pubmed-author:PressMM,
pubmed-author:SilbermanHH,
pubmed-author:SpicerDD,
pubmed-author:UzieliBB,
pubmed-author:WatkinsKK
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
39
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1059-68
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:9392545-Adult,
pubmed-meshheading:9392545-Antimetabolites, Antineoplastic,
pubmed-meshheading:9392545-Breast Neoplasms,
pubmed-meshheading:9392545-Combined Modality Therapy,
pubmed-meshheading:9392545-Disease-Free Survival,
pubmed-meshheading:9392545-Feasibility Studies,
pubmed-meshheading:9392545-Female,
pubmed-meshheading:9392545-Fluorouracil,
pubmed-meshheading:9392545-Humans,
pubmed-meshheading:9392545-Infusions, Intravenous,
pubmed-meshheading:9392545-Mastectomy, Modified Radical,
pubmed-meshheading:9392545-Middle Aged
|
pubmed:year |
1997
|
pubmed:articleTitle |
Original p53 status predicts for pathological response in locally advanced breast cancer patients treated preoperatively with continuous infusion 5-fluorouracil and radiation therapy.
|
pubmed:affiliation |
Department of Radiation Oncology, University of Southern California School of Medicine, Los Angeles 90033, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|